• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Rhett Wilkerson: Prior Authorization and Patient Access

Video

Rhett Wilkerson, associate director of patient financial services, Florida Cancer Specialists, discusses how utilization management strategies impact patient access to biologics.

Transcript

Yes, absolutely. So that's something that we work really hard with our utilization management team on we want to make sure that they have all the information available, because they really are kind of clicking those clinical boxes that says whether something should or shouldn't be supported.

So when they're when they're putting in that prior authorization information that they have everything they need to make the most appropriate selections, so that then there's less of a holdup, or denials, or things that have to go to peer-to-peer. We want it to be as smooth of a process as possible.

Newsletter

Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.

Recent Videos
Canavan & O’Dell
Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health.
Elena Wolff-Holz, MD.
© 2025 MJH Life Sciences

All rights reserved.